NCT05898347Completed
Nevoid Basal Cell Carcinomas in Gorlin Syndrome
Nevoid Basal Cell Carcinomas in Young People With Gorlin Syndrome
Source: ClinicalTrials.gov · Last updated 9 Oct 2026
Brief summary (registry, in English)
The overall aim of the project is to gain knowledge about the expected course of nevoid basal cell carcinomas and the usefulness of dermatoscopy in young individuals with Gorlin syndrome. Clinical experience and some case-reports suggest that nevoid basal cell carcinomas have an indolent course with slow growth and that they can sometimes regress. However, no systematic research has previously been performed. Increased knowledge about nevoid basal cell carcinomas and the use of dermatoscopy could be of great clinical value in the follow-up and treatment of individuals with nevoid basal cell carcinoma syndrome.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 7 (actual)
- First submitted
- 29 May 2023
- Start date
- 1 Jun 2023
- Primary completion date
- 20 Jun 2025
- Lead sponsor
- Oslo University Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT05898347
What you commit to
- Study type: Observational
- Participants enrolled: 7
- From 1 Jun 2023 to the primary completion date, 20 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- The patient has received topical treatment (imiquimod, 5-fluorouracil, photodynamic therapy and/or cryotherapy) of nevoid basal cell carcinomas during the last three months
Other illness
- The patient has a psychiatric disorder not compatible with completion of the study examinations
Who the study is looking for
- The individual has Gorlin syndrome (clinically and/or genetically diagnosed)
- The individual is minimum 6 years and maximum 17 years
- The individual has at least three skin lesions clinically compatible with nevoid basal cell carcinomas
Age in the registry: 6 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Oslo University Hospital Coordinator of this site? Confirm its status | Oslo | Norway | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.